XML 23 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue Recognition
 3 Months Ended
Sep. 30, 2021
Revenue Recognition  
Revenue Recognition

4. Revenue Recognition

Contract Balances. Contract assets primarily relate to the Company’s right to consideration in exchange for products transferred to a customer in which that right to consideration is dependent upon the customer selling these

products. As of September 30, 2021 and June 30, 2021, contract assets of $9,000 and $21,000 was included in other current assets in the condensed consolidated balance sheet. Contract liabilities primarily relate to advances or deposits received from the Company’s customers before revenue is recognized. As of September 30, 2021 and June 30, 2021, contract liabilities of $0.2 million were included in accrued liabilities in the consolidated balance sheet.

Revenues by Product Portfolio. Net revenue disaggregated by significant product portfolio for the three months ended September 30, 2021 and 2020 were as follows:

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

​

September 30, 

​

    

2021

    

2020

​

​

(In thousands)

Primary care and devices portfolio

 

$

425

 

$

3,033

Pediatric portfolio

​

​

13,458

​

​

2,719

Consumer Health portfolio

​

​

8,014

​

​

7,768

Consolidated revenue

 

$

21,897

 

$

13,520

​

​

Revenues by Geographic location. The following table reflects the Company’s product revenues by geographic location as determined by the billing address of customers:

​

​

​

​

​

​

​

​

​

    

Three Months Ended

​

​

September 30, 

​

    

2021

    

2020

​

​

(In thousands)

U.S.

​

$

21,106

​

$

12,144

International

​

 

791

​

 

1,376

Total net revenue

​

$

21,897

​

$

13,520

​